EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
01-12-2014
-31-05-2021
Show more information
Organisation
CENTRE MURAZ